Gynecologic Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Jill Baker
MDLinx Career Center
MGMA Data Breaks Down Physician Compensation

MDLinx Reminder
MDLinx
Did you see this newsletter?

Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC

MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?

MDLinx Conference Center
MDLinx
June Conference Calendar

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (10) Full Text Articles (316) Focus on Leukemia/lymphoma

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

181 Postoperative Radiotherapy for Uterine Cervical Cancer: Impact of Lymph Node and Histological Type on Survival Anticancer Research, May 8, 2013 Clinical Article

182 Pretreatment neutrophil-to-lymphocyte and platelet-to- lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy Full Text Chinese Medical Journal, May 8, 2013 Clinical Article

183 Tubal ligation, hysterectomy, and epithelial ovarian cancer in the New England case-control study International Journal of Cancer, May 7, 2013

184 A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy Gynecologic Oncology, May 7, 2013 Clinical Article

185 Contribution of Immunohistochemical Profile in Assessing Histological Grade of Endometrial Cancer Anticancer Research, May 7, 2013 Clinical Article

186 The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients Tumor Biology, May 7, 2013 Clinical Article

187 Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) British Journal of Cancer, May 6, 2013 Clinical Article

188 First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: a retrospective analysis of patients treated at brazilian national cancer institute International Journal of Gynecological Cancer, May 6, 2013 Clinical Article

189 Predictors of recovery of ovarian function during aromatase inhibitor therapy Annals of Oncology, May 6, 2013 Clinical Article

190 Galectin-7 Levels Predict Radiation Response in Squamous Cell Carcinoma of the Cervix Gynecologic Oncology, May 6, 2013 Clinical Article

191 Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy Radiotherapy & Oncology, May 3, 2013 Clinical Article

192 Disrupting Protein NEDDylation with MLN4924 is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer Clinical Cancer Research, May 3, 2013 Clinical Article

193 Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience Radiotherapy & Oncology, May 3, 2013 Clinical Article

194 Endometrial Cancer and a Family History of Cancer Gynecologic Oncology, May 3, 2013 Clinical Article

195 The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer Gynecologic Oncology, May 3, 2013 Clinical Article

196 Intensity Modulated Radiotherapy in Gynecologic Cancers: Hope, Hype or Hyperbole Gynecologic Oncology, May 3, 2013 Clinical Article

197 MicroRNAs and Recent Insights into Pediatric Ovarian Cancers Frontiers in Oncology, May 3, 2013 Clinical Article

198 Identifying serum biomarkers for ovarian cancer by screening with surface-enhanced laser desorption/ionization mass spectrometry and the artificial neural network International Journal of Gynecological Cancer, May 3, 2013 Clinical Article

199 Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase: A Novel Therapeutic Strategy in Ovarian Cancer International Journal of Gynecological Cancer, May 3, 2013 Clinical Article

200 Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN 2-3)? Gynecologic Oncology, May 2, 2013

50 available pages First Previous 10 11 12 13 14 15 16 17 18 19 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) British Journal of Cancer, May 6, 2013

2 Accuracy of Positron Emission Tomography/Computed Tomography in the Diagnosis and Restaging for Recurrent Ovarian Cancer: A Meta-Analysis International Journal of Gynecological Cancer, April 29, 2013 Evidence Based Medicine Review Article

3 First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: a retrospective analysis of patients treated at brazilian national cancer institute International Journal of Gynecological Cancer, May 6, 2013

4 A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy Gynecologic Oncology, May 7, 2013

5 Tubal ligation, hysterectomy, and epithelial ovarian cancer in the New England case-control study International Journal of Cancer, May 7, 2013

6 Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecologic Oncology, April 9, 2013

7 Predictors of recovery of ovarian function during aromatase inhibitor therapy Annals of Oncology, May 6, 2013

8 A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma Cancer Chemotherapy and Pharmacology, May 15, 2013

9 A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer British Journal of Cancer, May 23, 2013

10 Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial? American Journal of Clinical Oncology, May 24, 2013 Evidence Based Medicine

11 Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States Journal of Clinical Oncology, May 9, 2013

12 Nutritional status, CT body composition measures and survival in ovarian cancer Gynecologic Oncology, May 13, 2013

13 Endocervical glandular involvement, multicentricity, and extent of the disease are features of high-grade cervical intraepithelial neoplasia Annals of Diagnostic Pathology, May 15, 2013

14 HPV genotypes and risk of precancer Cancer Epidemiology, Biomarkers & Prevention, May 21, 2013

15 Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer British Journal of Cancer, May 10, 2013

16 Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group Study Gynecologic Oncology, April 18, 2013

17 Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions Gynecologic Oncology, May 15, 2013

18 Preserved foods associated with increased risk of ovarian cancer Gynecologic Oncology, May 15, 2013

19 Total laparoscopic radical trachelectomy in the treatment of early squamous cell cervical cancer: A retrospective study with 8-year follow-up Gynecologic Oncology, May 8, 2013

20 Physiological 18F-FDG uptake patterns in female reproductive organs before and after chemotherapy treatments: assessment by PET/CT Medical Oncology, May 9, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Gynecologic Oncology News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology